Nonproliferative retinopathy - Biotech, Pharma and Life Science Channel

17:10 EDT 1st July 2015 | BioPortfolio

PubMed Articles [283 Associated PubMed Articles listed on BioPortfolio]

Are reactive oxygen species still the basis for diabetic complications?

Despite the wealth of pre-clinical support for a role for reactive oxygen and nitrogen species (ROS/RNS) in the aetiology of diabetic complications, enthusiasm for antioxidant therapeutic approaches h...

Foxg1-Cre Mediated Lrp2 Inactivation in the Developing Mouse Neural Retina, Ciliary and Retinal Pigment Epithelia Models Congenital High Myopia.

Myopia is a common ocular disorder generally due to increased axial length of the eye-globe. Its extreme form high myopia (HM) is a multifactorial disease leading to retinal and scleral damage, visual...

COMPLETE RESOLUTION OF LARGE RETINAL FOLD AFTER TRANSECTION OF RETROLENTAL MEMBRANE DURING LENS-SPARING VITRECTOMY FOR RETINOPATHY OF PREMATURITY: A 15-YEAR FOLLOW-UP.

To describe the long-term anatomical and visual outcomes of a patient with retinopathy of prematurity characterized by a prominent retinal fold adherent to the posterior lens capsule, treated by lens-...

Restoration of synaptic function in sight for degenerative retinal disease.

Synaptic disorganization is a prominent feature of many neurological diseases of the CNS, including Parkinson's disease, intellectual development disorders, and autism. Although synaptic plasticity is...

Hemorrhagic Retinopathy after Spondylosis Surgery and Seizure.

To report bilateral hemorrhagic retinopathy in an adult female subject after lumbar spinal surgery and seizure.

Audiovestibular disorders as autoimmune reaction in patients with melanoma.

Melanoma is an aggressive form of cancer derived from neuroectodermal melanocytes. Melanocytes are present in the skin and hair follicles, as well as in the eye (iris and choroids), the leptomeninges,...

Comparative Effectiveness Trial for Diabetic Macular Edema: Three Comparisons for the Price of 1 Study From the Diabetic Retinopathy Clinical Research Network.

Diffuse Pigmentary Retinopathy and Preretinal and Perivascular Intraretinal Invasion of Choroidal Malignant Melanoma.

Review: Intensive blood pressure control reduces retinopathy in diabetes.

Prevalence and Cardiovascular Associations of Diabetic Retinopathy and Maculopathy: Results from the Gutenberg Health Study.

Diabetic retinopathy (DR) is the leading cause of blindness in people of working age. The purpose of this paper is to report the prevalence and cardiovascular associations of diabetic retinopathy and ...

News Articles [141 Associated News Articles listed on BioPortfolio]

New nanotechnology drug to control blindness

The Mexican company "Medical and Surgical Center for Retina" has created a way to deliver drugs in order to avoid risks and painful treatments in people with secondary blindness due to chronic degener...

Researchers ID Best Source of Stem Cells to Block Diabetic Blindness

University of Virginia School of Medicine researchers have taken a significant step forward in their efforts to use stem cells to block vision loss caused by diabetic retinopathy, a condition that aff...

New mVT® Research Shows Significant Value for AMD and DR Patients

Investigators confirm value of key features Vital Art and Science, LLC (VAS), an emerging ophthalmic medical device company, released four new studies in the continuing...

Diabetic blindness: Best source of stem cells to block vision loss

Stem cells taken from donors are more likely to be more effective at battling diabetic retinopathy than cells taken from patients' own bodies, a new study concludes. The work is a critical step toward...

Diabetic blindness: Team IDs best source of stem cells to block vision loss

University of Virginia School of Medicine researchers have taken a significant step forward in their efforts to use stem cells to block vision loss caused by diabetic retinopathy, a condition that aff...

Diabetic blindness: UVA IDs best source of stem cells to block vision loss

(University of Virginia Health System) Researchers have determined that stem cells taking from donors likely will be more effective at battling diabetic retinopathy than cells taken from patients' own...

DiabetesSeriesLive to Host CME Event on Strategies to Improve Treatment and Management of Diabetic Retinopathy

BOSTON, MA--(Marketwired - June 23, 2015) - Retina specialists, ophthalmologists, and primary care physicians will have an opportunity to learn new therapeutic advances in diabetic retinopathy live vi...

Rethinking Corcept Therapeutics (CORT), Part III of IV: Introduction to the New Pipeline

Rethinking Corcept: The Upcoming Pipeline It’s still early in Corcept’s portfolio development but important phase II trials are ongoing with independent investigators. Results should arrive o...

Rethinking Corcept Therapeutics (CORT), Part III of IV: Introduction to the Future Pipeline

Rethinking Corcept: The Upcoming Pipeline Important phase II trials are ongoing with independent investigators. These results should arrive over the next 15 to 18 months and enable Corcept create...

Ampio Pharmaceuticals Announces Additional Statistically Significant Study Results for Optina™ in the Treatment of Diabetic Macular Edema (DME)

ENGLEWOOD, Colo., June 22, 2015 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that further data analysis from the 12-week multi-center, placebo-controlled, double-m...

Events [0 Results]

None

Companies [6 Associated Companies listed on BioPortfolio]

Acucela Inc.

Acucela Inc. is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for treating blinding eye di...

Optos plc

Optos plc is a leading medical retinal imaging technology company. Both eye and non-eye diseases often first exhibit in the periphery of the retina. These are very difficult to de...

Promedior, Inc.

Promedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases. By...

NormOxys, Inc.

NormOxys is developing a novel class of small molecule drugs, oxyrens, which enhance the body’s ability to deliver oxygen more efficiently to diseased tissues with oxygen def...

Acucela

Acucela Inc. (www.acucela.com) is a clinical-stage biotechnology company focused on leveraging promising science in visual cycle modulation (VCM) to develop new methods for...

Allegro Ophthalmics, LLC

With more than 100 years of combined experience in vision science and medicine, the leadership team at Allegro Ophthalmics, LLC is establishing Integrin Peptide Therapy as the ...

Clinical Trials [180 Associated Clinical Trials listed on BioPortfolio]

UK Surveillance of Treated Retinopathy of Prematurity

Currently, there is little recent data on regional variations in treatment methods, neonatal units that provide retinopathy (ROP) treatment, facilities for treatment available at each unit...

Omega-3 LCPUFA Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of Prematurity

Retinopathy of prematurity (ROP) is a blinding disease affecting infants born prematurely. These infants do not have enough essential fatty acids to structurally support the retina, the ne...

Study of Topical Ocular PAN-90806 in PDR

The objective of this study is to assess the safety and tolerability of topical ocular PAN-90806 in patients with proliferative diabetic retinopathy.

Analyses of Existing Framingham Data

Since 1948, the Framingham Study has examined a group of men and women every two years for the primary purpose of studying the incidence and prevalence of cardiovascular disease and its ri...

Study of Effectiveness of Telemedicine in Identifying Diabetic Retinopathy Cases

The aim of this study is to compare the effectiveness of identifying diabetic retinopathy using tele-medicine based Digital Retinal Imaging in Diabetes Clinics with that of the conventiona...

Prevalence of Peripheral Neuropathy in Children and Adolescents With Type I Diabetes Mellitus: a Prospective Study

Diabetes mellitus type I is an increasing burden for more and younger children. Therapy should avoid long-term complications as macrovascular diseases and diabetic nephropathy, retinopathy...

Study of Intravitreal REGN2176-3 in Patients With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)

The primary objective of the study is to explore the effect of REGN2176-3 on the Early Treatment Diabetic Retinopathy Scale (ETDRS) best-corrected visual acuity (BCVA) in patients with neo...

Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

The primary objective of the protocol is to determine if visual acuity outcomes at 2 years in eyes with proliferative diabetic retinopathy (PDR) that receive anti-vascular endothelial grow...

Analysis of Angiogenic Factor Levels in Eyes With Diabetic Retinopathy

This study was conducted to investigate the levels of angiogenic factors and anti-angiogenic factors in the aqueous humor of patients with diabetic retinopathy.

TES for the Treatment of RP

Retinitis pigmentosa (RP) is a progressive degenerative disease of the retina, which often leads to blindness. 1 in 4000 people in the UK are affected by RP yet there is no established the...

Videos

None available.

Medical and Biotech [MESH] Definitions

A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)

Degenerative changes to the RETINA due to HYPERTENSION.

A drug used to reduce hemorrhage in diabetic retinopathy.

Removal of the whole or part of the vitreous body in treating endophthalmitis, diabetic retinopathy, retinal detachment, intraocular foreign bodies, and some types of glaucoma.

Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.


Advertisement
 
Advertisement
 
review and buy Nonproliferative retinopathy market research data and corporate reports here

Channels Quicklinks